Puromycin: action on neuronal mitochondria.
Puromycin, in dosages that inhibit cerebral protein synthesis and expression of memory in mice, produces swelling of neuronal mitochondria. Acetoxycycloheximide, which inhibits cerebral protein synthesis to the same extent as puromycin, fails to produce swelling of neuronal mitochondria. Puromycin and heximide mixtures produce severe inhibition of protein synthesis, but result in a minimal swelling of neuronal mitochondria and in a decrease of peptidylpuromycin complexes to a level of 30 percent of that following the injection of puromycin alone. It is concluded that swelling of neuronal mitochondria in the presence of puromycin is not due to inhibition of cerebral protein synthesis per se, but is related to a specific action of puromycin on ribosomal protein synthesis. The findings are consistent with the hypothesis that peptidyl-puromycin complexes are responsible for mitochondrial swelling.
D000818:Animals; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D003513:Cycloheximide / Q000494:pharmacology; D003864:Depression, Chemical; D008568:Memory; D051379:Mice; D008854:Microscopy, Electron; D008928:Mitochondria / Q000187:drug effects* / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D010455:Peptides / Q000032:analysis / Q000378:metabolism; D011691:Puromycin / Q000494:pharmacology*; D012270:Ribosomes; D014238:Trichloroacetic Acid; D014316:Tritium
D009419:Nerve Tissue Proteins; D010455:Peptides; D014316:Tritium; D011691:Puromycin; D014238:Trichloroacetic Acid; D003513:Cycloheximide